Famitinib malate
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for Famitinib malate, covering 2013-12-03 to 2026-01-21. Get the full timeline:
Most recent: Clinical Trial Update: A Randomized, Open-label, Double-cohort Study of Fluzoparib Combined With Famitinib Malate or SHR-1701 for Neoadjuvant Therapy in Patients With Advanced Ovarian Cancer [Phase 2]